Enteral nutrition and cardiovascular medications in the pediatric intensive care unit.
King
Wendalyn
W
Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, USA. wendy_king@oz.ped.emory.edu
Petrillo
Toni
T
Pettignano
Robert
R
D000293:Adolescent; D000328:Adult; D002317:Cardiovascular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003422:Critical Care / Q000379:methods; D016638:Critical Illness / Q000628:therapy*; D004280:Dobutamine / Q000009:adverse effects / Q000627:therapeutic use; D004298:Dopamine / Q000009:adverse effects / Q000627:therapeutic use; D004750:Enteral Nutrition / Q000009:adverse effects; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D015278:Intensive Care Units, Pediatric; D008297:Male; D009638:Norepinephrine / Q000009:adverse effects / Q000627:therapeutic use; D010656:Phenylephrine / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D012449:Safety
D002317:Cardiovascular Agents; D010656:Phenylephrine; D004280:Dobutamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine